Analysis of the methods for projection of spaces for good manufacturing practice
Article Sidebar
Main Article Content
Abstract
BACKGROUND: In this Paper we will present the evolution of the best practice for biobanks, the technical and medical standards for collecting, processing and storing, as well as the socio-economic standards for biobank management.
AIM: The aim of this Thesis is to analyse and to present the methods for projection of spaces for good manufacturing practice.
METHODS: The European Union has adopted guidelines for good manufacturing practice which define the requirements for manufacturing of sterile products. In the following text we will describe the details for determining microbiological cleanliness and cleanliness of the particles in the air, on the surfaces, etc.
RESULTS: The length of time between the collecting of blood or tissues could affect the final result. The preparation of sterile products requires special conditions, in order the risk of microbiological contamination and certain pyrogenic contaminations to be minimized. We make difference between four levels of guidelines for good manufacturing practice, which in this Paper are taken from the practice of the European Union. Level A is local zone with high-risk procedures, e.g. filling, closing of bottles, opening of ampoules and bottles and making septic connections. Level B is aseptic preparation and filling of the samples. Level C and D are the clean spaces for less critical procedures for preparation of sterile products.
CONCLUSION: Technical standards, medical standards, socio-economic standards for biobank management, informatics practices for biobanks, economic recommendations for biobanks have been established, as well as a quality of biobanks has been provided.
Downloads
Plum Analytics Artifact
Article Details
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
The South East European Journal of Architecture and Design (SEEJAD) applies the Creative Commons Attribution License (CCAL) to all works we publish (read the human-readable summary or the full license legal code). Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in OAMJMS journal, so long as the original authors and source are cited. No permission is required from the authors or the publishers.
In most cases, appropriate attribution can be provided by simply citing the original article (e.g. Gogusev J, Chretien Y, Droz D. Aberrant Expression of Polycystin-1 in Renal Cell Tumors. Maced J Med Sci. 2008;1(1):11-16. doi:10.3889/MJMS.1857-5773.2008.0004). If the item you plan to reuse is not part of a published article (e.g. a featured issue image), then please indicate the originator of the work, and the volume, issue and date of the journal in which the item appeared. For any reuse or redistribution of a work, you must also make clear the license terms under which the work was published.
This broad license was developed to facilitate open access to, and free use of, original works of all types. Applying this standard license to your own work will ensure your right to make your work freely and openly available. Learn more about open access. For queries about the license, please contact us.
References
Eiseman E, Haga SB, editors. Handbook of human tissue sources: a national resource of human tissue samples. Santa Monica, CA: RAND Corporation; 1999.
Riegman PH, Dinjens WN, Oosterhuis JW. Biobanking for interdisciplinary clinical research. Pathobiology. 2007; 74:239-44.
https://doi.org/10.1159/000104451 DOI: https://doi.org/10.1159/000104451
Hughes S, Barnes RO, Watson PH. Biospecimen use in cancer research over two decades. Biopreserv Biobanking. 2010; 8:89-97. https://doi.org/10.1089/bio.2010.0005 DOI: https://doi.org/10.1089/bio.2010.0005
Vaught J, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010; 19:912-5. https://doi.org/10.1158/1055-9965.EPI-10-0058
Moore HM, Compton CC, Alper J, Vaught JB. International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev. 2011; 20:729-32. https://doi.org/10.1158/1055-9965.EPI-11-0021 DOI: https://doi.org/10.1158/1055-9965.EPI-11-0021
Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera YW, et al. Perioperative ischemia and tissue preservation effects on RNA integ239rity and microarrays of breast cancer. J Natl Cancer Inst. 2011; 103:1871-83. https://doi.org/10.1093/jnci/djr438 DOI: https://doi.org/10.1093/jnci/djr438
Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ. Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum. Clin Chem. 2001; 47:139-42. https://doi.org/10.1093/clinchem/47.1.139 DOI: https://doi.org/10.1093/clinchem/47.1.139
Vaught JB. Blood collection, shipment, processing and storage. Cancer Epidemiol Biomarkers Prev. 2006; 15:1582-4. https://doi.org/10.1158/1055-9965.EPI-06-0630 DOI: https://doi.org/10.1158/1055-9965.EPI-06-0630
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Khoury T, Sai S, Hwang J, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol. 2009; 22:1457-67. https://doi.org/10.1038/modpathol.2009.117 DOI: https://doi.org/10.1038/modpathol.2009.117
ISBER best practices for repositories. Cell Preserv Technol. 2008; 6:1-58. https://doi.org/10.1089/cpt.2008.9996 DOI: https://doi.org/10.1089/cpt.2008.9996
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Vaught J, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010; 19:912-5. https://doi.org/10.1158/1055-9965.EPI-10-0058 DOI: https://doi.org/10.1158/1055-9965.EPI-10-0058
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a national cancer human biobank by the National Cancer Institute. JNCI Monogr. 2011; 42:24-31. https://doi.org/10.1093/jncimonographs/lgr009
Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a national cancer human biobank by the National Cancer Institute. JNCI Monogr. 2011; 42:24-31. https://doi.org/10.1093/jncimonographs/lgr009 DOI: https://doi.org/10.1093/jncimonographs/lgr009
Centers for Disease Control and Prevention laboratory quality assurance and standardization program. http://www.cdc.gov/labstandards/ Accessed March 9, 2012.
Master Control web site. http://www.mastercontrol.com/document-control-software/ Accessed March 9, 2012.
Centers for Disease Control and Prevention laboratory quality assurance and standardization program. http://www.cdc.gov/labstandards/ Accessed March 9, 2012.
EudraLex. The Rules Governing Medicinal Products in the European Union. Volume 4. EU Guidelines to Good Manufacturing Medicinal Products for Human and Veterinary Use. EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL: Brussels, 25 November 2008.
EudraLex. The Rules Governing Medicinal Products in the European Union. Volume 4. EU Guidelines to Good Manufacturing Medicinal Products for Human and Veterinary Use. EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL: Brussels, 25 November 2008.
UNI-EN-ISO 14644-1/2/3/4/5/7 regulations.